Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis (ACCESS)
This study is currently recruiting participants.
Study NCT00774852 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: October 16, 2008 Last Updated: September 22, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lupus Nephritis
Lupus Erythematosus, Systemic
Additional conditions recognized in this trial
Nephritis
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Glomerulonephritis
Immune System Diseases
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
Abatacept
cyclophosphamide
azathioprine
prednisone
abatacept placebo
azathioprine placebo
More general drug interventions related to this trial
Alkylating Agents
Anti-Inflammatory Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network
Back to top of Main Content
